Literature DB >> 2015330

Effects of chronic lithium treatment on protein kinase C and cyclic AMP-dependent protein phosphorylation.

T L Casebolt1, R S Jope.   

Abstract

Lithium inhibits the agonist-induced hydrolysis of phosphoinositides and the synthesis of cyclic AMP (cAMP) in rat brain preparations, each of which is linked to activation of specific protein kinases. Therefore, we examined the effects of chronic lithium treatment on protein kinase activities in rat hippocampus. Chronic lithium treatment did not alter the distribution or activity of protein kinase C in hippocampal soluble or particulate fractions. However, chronic lithium treatment increased protein kinase C-mediated phosphorylation of four endogenous proteins in the soluble fraction (16,17,20,22 kD) and reduced the phosphorylation of three proteins (18,19,87 kD) in the particulate fraction. Chronic lithium treatment did not alter cAMP-dependent phosphorylation of endogenous proteins in the soluble fraction but reduced phosphorylation of two proteins (54 and 71 kD) in the particulate fractions. These results demonstrate that besides inhibiting second messenger production in brain, chronic lithium treatment also causes specific alterations in the phosphorylation of endogenous proteins.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2015330     DOI: 10.1016/0006-3223(91)91285-y

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  10 in total

1.  Circadian variation in rat brain AP-1 DNA binding activity after cholinergic stimulation: modulation by lithium.

Authors:  M B Williams; R S Jope
Journal:  Psychopharmacology (Berl)       Date:  1995-12       Impact factor: 4.530

2.  Decreased protein kinase C (PKC) in platelets of pediatric bipolar patients: effect of treatment with mood stabilizing drugs.

Authors:  Ghanshyam N Pandey; Xinguo Ren; Yogesh Dwivedi; Mani N Pavuluri
Journal:  J Psychiatr Res       Date:  2007-01-08       Impact factor: 4.791

Review 3.  A Role for Phosphodiesterase 11A (PDE11A) in the Formation of Social Memories and the Stabilization of Mood.

Authors:  Michy P Kelly
Journal:  Adv Neurobiol       Date:  2017

Review 4.  Role of Protein Kinase C in Bipolar Disorder: A Review of the Current Literature.

Authors:  Ashwini Saxena; Giselli Scaini; Daniela V Bavaresco; Camila Leite; Samira S Valvassori; André F Carvalho; João Quevedo
Journal:  Mol Neuropsychiatry       Date:  2017-10-07

5.  Hydrolysis of exogenous [3H]phosphatidylcholine by brain membranes and cytosol.

Authors:  L Song; M S Baird; R S Jope
Journal:  Neurochem Res       Date:  1993-12       Impact factor: 3.996

6.  Lithium-mediated phosphorylation of glycogen synthase kinase-3beta involves PI3 kinase-dependent activation of protein kinase C-alpha.

Authors:  Noa Kirshenboim; Batya Plotkin; Shani Ben Shlomo; Oksana Kaidanovich-Beilin; Hagit Eldar-Finkelman
Journal:  J Mol Neurosci       Date:  2004       Impact factor: 3.444

7.  Adenylate cyclase regulates elongation of mammalian primary cilia.

Authors:  Young Ou; Yibing Ruan; Min Cheng; Joanna J Moser; Jerome B Rattner; Frans A van der Hoorn
Journal:  Exp Cell Res       Date:  2009-07-02       Impact factor: 3.905

8.  PDE11A negatively regulates lithium responsivity.

Authors:  G Pathak; M J Agostino; K Bishara; W R Capell; J L Fisher; S Hegde; B A Ibrahim; K Pilarzyk; C Sabin; T Tuczkewycz; S Wilson; M P Kelly
Journal:  Mol Psychiatry       Date:  2016-09-20       Impact factor: 15.992

Review 9.  Is There Justification to Treat Neurodegenerative Disorders by Repurposing Drugs? The Case of Alzheimer's Disease, Lithium, and Autophagy.

Authors:  Odeya Damri; Nofar Shemesh; Galila Agam
Journal:  Int J Mol Sci       Date:  2020-12-27       Impact factor: 5.923

Review 10.  Lithium as a Neuroprotective Agent for Bipolar Disorder: An Overview.

Authors:  Enrique L M Ochoa
Journal:  Cell Mol Neurobiol       Date:  2021-08-06       Impact factor: 5.046

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.